Abdullah, Zahra .

HRN: 27-56-75  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/31/2025
CEFUROXIME 750MG (VIAL)
07/31/2025
08/07/2025
IV
150mg
Q8
PCAP C
Checking Initial Appropriateness 
08/01/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
08/01/2025
08/07/2025
IVT
45mg
Q24
PCAP-C
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: